Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT06656715
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
To describe and compare the symptom burden in cancer patients with concurrent diagnosis of heart failure (HFrEF compared to HFpEF).
Key Dates
- Start date
- Dec 16, 2024
- Status verified
- Dec 2025
- Primary completion
- Sep 1, 2026
- Completion
- Sep 1, 2028
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: SingleArmSymptom Assessment and Comparison
Primary Outcome Measure
Heart Failure [ Time Frame: Through study completion, an average of 3 years ]
Central Contacts
- Anceita Fadol, MSN,PHD,RN832-817-8997
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas of MD Anderson Cancer Center | Houston | Texas | 77030 | Anecita P Fadol, MSN,PHD,RN (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By condition
By specialty
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Get With The Guidelines-Heart Failure RegistryRecruiting · American Heart Association · Dallas, Texas
- Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by AnthracyclinesPHASE1 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas